Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16542592 | 0.88 | TSHR (0.38) | GAAALDH1A1MAPTPTGS1HMGCR | |
| SCHEMBL9294282 | 0.87 | GAA (0.40) | GAAALDH1A1MAPTPTGS1TDP1 | |
| SCHEMBL673097 | 0.87 | GAA (0.35) | GAAALDH1A1MAPTPTGS1TDP1 | |
| SCHEMBL19696492 | 0.86 | GAA (0.31) | GAA | |
| SCHEMBL22562661 | 0.86 | LMNA (0.35) | GAAALDH1A1MAPTPTGS1TDP1 | |
| SCHEMBL15799937 | 0.84 | GAA (0.33) | GAATSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL23266468 | 0.82 | GAA (0.32) | GAA | |
| SCHEMBL9947047 | 0.82 | ALDH1A1 (0.39) | GAAALDH1A1MAPTPTGS1 | |
| SCHEMBL13262289 | 0.82 | ALDH1A1 (0.33) | GAAALDH1A1MAPTPTGS1LMNA | |
| SCHEMBL14297758 | 0.82 | GAA (0.32) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2513141-B1 | GLP-1 ANALOGUES AND DERIVATIVES | NOVO NORDISK AS (DK) | 2017-03-01 | — | — | EP | disclosed |
| US-7803568-B2 | Carbodithioate ligands for nanotechnology and biosensing applications | PURDUE RESEARCH FOUNDATION (US) | 2010-09-28 | — | — | US | disclosed |
| US-7695820-B2 | homo or comonomers selected from 1,6-dicarbonyl- 2,2,5,5- tetramethyl- hexane, 1,7-dicarbonyl- 2,2,6,6- tetramethyl- heptane, 1,9-dicarbonyl- 2,8-diethyl- 2,8-dimethyl- nonane and diols selected from 2,2-diethyl-1,3-propanediol, 2-ethyl-2-methyl-1,3-propanediol; lubrication for disk drive; heat resistanc | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2010-04-13 | — | — | US | disclosed |
| US-20080124776-A1 | Carbodithioate Ligands For Nanotechnology and Methods of Use | NATIONAL SCIENCE FOUNDATION | 2008-05-29 | — | — | US | disclosed |
| US-20070203212-A1 | METHOD OF TREATING OSTEOARTHRITIS | WARNER-LAMBERT COMPANY (US) | 2007-08-30 | — | — | US | disclosed |
| US-20070111037-A1 | ALIPHATIC POLYESTERS AND LUBRICANTS CONTAINING THE POLYESTERS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203212-A1 | METHOD OF TREATING OSTEOARTHRITIS | SYVN1, MMP13, TNF | GAA 3294/4885ALDH1A1 636/4885MAPT 3942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.